Discover stories from Breakthrough T1D about our research, advocacy, initiatives, and supporters.
Lee las últimas noticias de Breakthrough T1D.
Islet cell therapies for type 1 diabetes (T1D) replace destroyed insulin-producing beta cells with functional cells that allow the body to make insulin again. To ensure there are enough islet cells for everyone with T1D who wants them, Breakthrough T1D is prioritizing manufactured cell therapies, which can be made in large quantities in a laboratory, […]
It was identified in the late 1960s. Since then, studies have shown that it is a biomarker for beta cell function. In other words, it’s a measure of beta cell health and insulin production. If it’s low (or you have none), it indicates that your pancreas is producing little or no insulin. There was even […]
What’s happening? The U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type 1 diabetes (T1D) ages one and older. This is a huge win for the T1D community! Breakthrough T1D applauds the FDA for this approval and Sanofi for their commitment to new therapies for the T1D […]
Karen Shishino Jordan, a long-time volunteer leader in the greater California Bay area, will serve as Breakthrough T1D (formerly JDRF) International Board of Directors (IBOD) Chair, succeeding current Chair Lisa Fishbone Wallack. Carlton McMillan, also a dedicated volunteer leader in the greater California Bay area, will serve as Vice Chair, succeeding current Vice Chair Matt Varey. Karen’s and Carlton’s terms as Chair and Vice Chair, respectively, begin Wednesday, July 1, 2026. Breakthrough […]
Remember how fun it was to be on the couch with your friends, fire up your Nintendo console, and play video games late into the night? Heroes of Time captures that magic but adds in 33 talented creators, a massive audience, and creative fundraising. It’s all in support of Breakthrough T1D Play and our work […]
Breakthrough T1D Ride is a charitable cycling event that has raised over $77 million for type 1 diabetes (T1D) research, which has directly led to innovations like continuous glucose monitors (CGMs) and disease-modifying therapies that can slow the progression of T1D. Ride offers cyclists of every age and skill level the chance to fuel breakthroughs […]
Lee los últimos comunicados de prensa y declaraciones de Breakthrough T1D.
¡Vaya! No hemos podido localizar tu formulario.
